Breaking News Instant updates and real-time market news.

PXD

Pioneer Natural

$157.03 /

+0.04 (+0.03%)

18:40
09/17/21
09/17
18:40
09/17/21
18:40

Pioneer Natural launches sale of assets in Delaware basin of Texas, Reuters says

Pioneer Natural Resources has put its assets in the Delaware basin of Texas up for sale, looking to secure more than $2B for the properties, Reuters' Arathy Nair, David French, and Shariq Khan report, citing two sources familiar with the matter. Reference Link

  • 01

    Dec

  • 11

    May

PXD Pioneer Natural
$157.03 /

+0.04 (+0.03%)

09/09/21
Fly Intel: Top five analyst upgrades
09/09/21 Goldman Sachs
Pioneer Natural upgraded to Conviction Buy from Buy at Goldman Sachs
07/22/21 Piper Sandler
Pioneer Natural price target raised to $218 from $216 at Piper Sandler
07/15/21 Mizuho
Pioneer Natural price target raised to $231 from $224 at Mizuho

TODAY'S FREE FLY STORIES

Hot Stocks
Innovid announces PIPE investment expansion to $200M » 07:05
10/20/21
10/20
07:05
10/20/21
07:05
IACB

ION Acquisition Corp 2

$9.92 /

+0.01 (+0.10%)

Innovid and ION…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IACB ION Acquisition Corp 2
$9.92 /

+0.01 (+0.10%)

IACB ION Acquisition Corp 2
$9.92 /

+0.01 (+0.10%)

Hot Stocks
BeiGene, Nanolek receive Russia Ministry of Health approval for Brukinsa » 07:05
10/20/21
10/20
07:05
10/20/21
07:05
BGNE

BeiGene

$375.76 /

+14.29 (+3.95%)

BeiGene and Nanolek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$375.76 /

+14.29 (+3.95%)

BGNE BeiGene
$375.76 /

+14.29 (+3.95%)

10/12/21
Fly Intel: Top five analyst initiations
10/12/21 Bernstein
BeiGene initiated with Outperform, $431 price target at Bernstein
10/12/21 Bernstein
BeiGene initiated with an Outperform at Bernstein
10/06/21 CLSA
CLSA double upgrades BeiGene to Buy on anti-BTK potential
BGNE BeiGene
$375.76 /

+14.29 (+3.95%)

  • 02
    Dec
BGNE BeiGene
$375.76 /

+14.29 (+3.95%)

BGNE BeiGene
$375.76 /

+14.29 (+3.95%)

General news
Week of 10/15 MBA refinance index down 7.0%  07:05
10/20/21
10/20
07:05
10/20/21
07:05
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
Week of 10/15 MBA purchase index down 5.0%  07:05
10/20/21
10/20
07:05
10/20/21
07:05
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
Week of 10/15 MBA composite index down 6.3%  07:05
10/20/21
10/20
07:05
10/20/21
07:05
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
Winnebago reports Q4 adjusted EPS $2.57, consensus $2.01 » 07:04
10/20/21
10/20
07:04
10/20/21
07:04
WGO

Winnebago

$72.28 /

-0.2 (-0.28%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WGO Winnebago
$72.28 /

-0.2 (-0.28%)

WGO Winnebago
$72.28 /

-0.2 (-0.28%)

10/01/21 BMO Capital
Winnebago price target raised to $100 from $90 at BMO Capital
07/01/21 Raymond James
Winnebago initiated with Market Perform on margin concerns at Raymond James
07/01/21 Raymond James
Winnebago initiated with a Market Perform at Raymond James
06/24/21 BMO Capital
Winnebago Q3 results saw significant improvement, says BMO Capital
WGO Winnebago
$72.28 /

-0.2 (-0.28%)

WGO Winnebago
$72.28 /

-0.2 (-0.28%)

Hot Stocks
LumiraDx receives approval for its COVID-19 Antigen test for use in India » 07:04
10/20/21
10/20
07:04
10/20/21
07:04
LMDX

LumiraDx

$8.41 /

+0.5 (+6.32%)

LumiraDx announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LMDX LumiraDx
$8.41 /

+0.5 (+6.32%)

LMDX LumiraDx
$8.41 /

+0.5 (+6.32%)

08/31/21 Ladenburg
Ladenburg starts CA Healthcare Acquisition at Buy ahead of LumiraDx deal
LMDX LumiraDx
$8.41 /

+0.5 (+6.32%)

Hot Stocks
Nasdaq narrows 2021 operating expense guidance $1.6B-$1.62B » 07:04
10/20/21
10/20
07:04
10/20/21
07:04
NDAQ

Nasdaq

$208.57 /

+5.13 (+2.52%)

The company is narrowing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

10/19/21 Citi
Nasdaq price target raised to $203 from $193 at Citi
09/14/21 Atlantic Equities
CME Group upgraded to Overweight at Atlantic Equities following underperformance
08/18/21 Raymond James
Cboe could be 'in play' after takeover report denied, says Raymond James
08/03/21 Morgan Stanley
Apollo Global, Nasdaq named Diversified Financials Top Picks at Morgan Stanley
NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

Recommendations
Netflix price target raised to $706 from $625 at Wolfe Research » 07:03
10/20/21
10/20
07:03
10/20/21
07:03
NFLX

Netflix

$639.47 /

+1.62 (+0.25%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

06:50 Today Stifel
Netflix price target raised to $690 from $650 at Stifel
06:43 Today Baird
Netflix shares should bought aggressively on any weakness, says Baird
06:36 Today Barclays
Netflix price target raised to $675 from $625 at Barclays
06:17 Today Deutsche Bank
Deutsche Bank downgrades Netflix on valuation, keeps $590 price target
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

Hot Stocks
Elevation Oncology promoties Valerie Malyvanh Jansen to Chief Medical Officer » 07:03
10/20/21
10/20
07:03
10/20/21
07:03
ELEV

Elevation Oncology

$7.79 /

+0.14 (+1.83%)

Elevation Oncology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELEV Elevation Oncology
$7.79 /

+0.14 (+1.83%)

ELEV Elevation Oncology
$7.79 /

+0.14 (+1.83%)

07/20/21
Fly Intel: Top five analyst initiations
07/20/21 Cowen
Cowen starts precision oncology company Elevation at Outperform
07/20/21 Wedbush
Elevation Oncology initiated with an Outperform at Wedbush
07/20/21 SVB Leerink
Elevation Oncology initiated with an Outperform at SVB Leerink
  • 25
    Jun
ELEV Elevation Oncology
$7.79 /

+0.14 (+1.83%)

Hot Stocks
Stepan Company invests $220M to build new alkoxylation plant in Texas » 07:03
10/20/21
10/20
07:03
10/20/21
07:03
SCL

Stepan Company

$119.04 /

+0.45 (+0.38%)

Stepan Company announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

01/11/21 Seaport Global
Stepan Company downgraded to Neutral from Buy at Seaport Global
10/22/20 Stifel
Stepan Company price target raised to $130 from $122 at Stifel
SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

Earnings
Nasdaq reports Q3 adjusted EPS $1.78, consensus $1.72 » 07:02
10/20/21
10/20
07:02
10/20/21
07:02
NDAQ

Nasdaq

$208.57 /

+5.13 (+2.52%)

Reports Q3 revenue $838M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

10/19/21 Citi
Nasdaq price target raised to $203 from $193 at Citi
09/14/21 Atlantic Equities
CME Group upgraded to Overweight at Atlantic Equities following underperformance
08/18/21 Raymond James
Cboe could be 'in play' after takeover report denied, says Raymond James
08/03/21 Morgan Stanley
Apollo Global, Nasdaq named Diversified Financials Top Picks at Morgan Stanley
NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

NDAQ Nasdaq
$208.57 /

+5.13 (+2.52%)

Hot Stocks
Red Cat's Teal Drones opens U.S. manufacturing facility » 07:02
10/20/21
10/20
07:02
10/20/21
07:02
RCAT

Red Cat

$2.85 /

-0.105 (-3.56%)

Red Cat Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCAT Red Cat
$2.85 /

-0.105 (-3.56%)

RCAT Red Cat
$2.85 /

-0.105 (-3.56%)

06/07/21 ThinkEquity
Red Cat initiated with a Buy at ThinkEquity
RCAT Red Cat
$2.85 /

-0.105 (-3.56%)

  • 19
    Jul
  • 30
    Apr
RCAT Red Cat
$2.85 /

-0.105 (-3.56%)

RCAT Red Cat
$2.85 /

-0.105 (-3.56%)

Downgrade
Hennes & Mauritz downgraded to Underweight from Equal Weight at Morgan Stanley » 07:01
10/20/21
10/20
07:01
10/20/21
07:01
HNNMY

Hennes & Mauritz

$3.92 /

+0.07 (+1.82%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HNNMY Hennes & Mauritz
$3.92 /

+0.07 (+1.82%)

10/06/21 Deutsche Bank
Hennes & Mauritz price target lowered to SEK 145 from SEK 150 at Deutsche Bank
10/01/21 Credit Suisse
Hennes & Mauritz price target lowered to SEK 157 from SEK 163 at Credit Suisse
09/17/21 Morgan Stanley
Hennes & Mauritz price target lowered to SEK 185 from SEK 200 at Morgan Stanley
08/26/21 JPMorgan
Hennes & Mauritz price target raised to SEK 220 from SEK 216 at JPMorgan
HNNMY Hennes & Mauritz
$3.92 /

+0.07 (+1.82%)

Hot Stocks
Stepan Company increases quarterly dividend, authorizes $150M share repurchase » 07:01
10/20/21
10/20
07:01
10/20/21
07:01
SCL

Stepan Company

$119.04 /

+0.45 (+0.38%)

The board of directors of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

01/11/21 Seaport Global
Stepan Company downgraded to Neutral from Buy at Seaport Global
10/22/20 Stifel
Stepan Company price target raised to $130 from $122 at Stifel
SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

Hot Stocks
Stepan Company says supply chain disruptions continue to impact the company » 06:59
10/20/21
10/20
06:59
10/20/21
06:59
SCL

Stepan Company

$119.04 /

+0.45 (+0.38%)

"The Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

01/11/21 Seaport Global
Stepan Company downgraded to Neutral from Buy at Seaport Global
10/22/20 Stifel
Stepan Company price target raised to $130 from $122 at Stifel
SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

Downgrade
Boohoo downgraded to Underweight from Equal Weight at Morgan Stanley » 06:59
10/20/21
10/20
06:59
10/20/21
06:59
BHOOY

Boohoo

$53.68 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHOOY Boohoo
$53.68 /

+ (+0.00%)

BHOOY Boohoo
$53.68 /

+ (+0.00%)

10/08/21 Berenberg
Boohoo price target lowered to 350 GBp from 460 GBp at Berenberg
10/08/21 Credit Suisse
Boohoo price target lowered to 265 GBp from 350 GBp at Credit Suisse
10/06/21 Deutsche Bank
Boohoo price target lowered to 370 GBp from 400 GBp at Deutsche Bank
10/04/21 Barclays
Boohoo price target lowered to 415 GBp from 530 GBp at Barclays
Earnings
Stepan Company reports Q3 adjusted EPS $1.57, consensus $1.42 » 06:57
10/20/21
10/20
06:57
10/20/21
06:57
SCL

Stepan Company

$119.04 /

+0.45 (+0.38%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

01/11/21 Seaport Global
Stepan Company downgraded to Neutral from Buy at Seaport Global
10/22/20 Stifel
Stepan Company price target raised to $130 from $122 at Stifel
SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

SCL Stepan Company
$119.04 /

+0.45 (+0.38%)

Earnings
M&T Bank reports Q3 EPS $3.69, consensus $3.50 » 06:52
10/20/21
10/20
06:52
10/20/21
06:52
MTB

M&T Bank

$151.39 /

+0.57 (+0.38%)

Reports Q3 CET1 capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTB M&T Bank
$151.39 /

+0.57 (+0.38%)

MTB M&T Bank
$151.39 /

+0.57 (+0.38%)

10/11/21 Jefferies
M&T Bank price target raised to $172 from $145 at Jefferies
10/01/21 Citi
M&T Bank upgraded to Buy from Neutral at Citi
07/22/21 Wedbush
M&T Bank price target lowered to $158 from $171 at Wedbush
07/22/21 Wells Fargo
M&T Bank price target lowered to $155 from $168 at Wells Fargo
MTB M&T Bank
$151.39 /

+0.57 (+0.38%)

MTB M&T Bank
$151.39 /

+0.57 (+0.38%)

MTB M&T Bank
$151.39 /

+0.57 (+0.38%)

Initiation
Cyclerion Therapeutics initiated with a Buy at Truist » 06:51
10/20/21
10/20
06:51
10/20/21
06:51
CYCN

Cyclerion Therapeutics

$2.65 /

+0.07 (+2.71%)

Truist analyst Joon Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYCN Cyclerion Therapeutics
$2.65 /

+0.07 (+2.71%)

CYCN Cyclerion Therapeutics
$2.65 /

+0.07 (+2.71%)

06:13 Today Truist
Cyclerion Therapeutics initiated with a Buy at Truist
09/24/21 Cantor Fitzgerald
Cyclerion Therapeutics initiated with an Overweight at Cantor Fitzgerald
CYCN Cyclerion Therapeutics
$2.65 /

+0.07 (+2.71%)

Recommendations
Netflix price target raised to $690 from $650 at Stifel » 06:50
10/20/21
10/20
06:50
10/20/21
06:50
NFLX

Netflix

$639.47 /

+1.62 (+0.25%)

Stifel analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

06:43 Today Baird
Netflix shares should bought aggressively on any weakness, says Baird
06:36 Today Barclays
Netflix price target raised to $675 from $625 at Barclays
06:17 Today Deutsche Bank
Deutsche Bank downgrades Netflix on valuation, keeps $590 price target
06:11 Today Deutsche Bank
Netflix downgraded to Hold from Buy at Deutsche Bank
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

Earnings
Gray Television sees Q3 revenue $590M-$600M, consensus $589.51M  06:50
10/20/21
10/20
06:50
10/20/21
06:50
GTN

Gray Television

$22.82 /

+0.08 (+0.35%)

 
ShowHide Related Items >><<
GTN Gray Television
$22.82 /

+0.08 (+0.35%)

GTN Gray Television
$22.82 /

+0.08 (+0.35%)

05/10/21 Barrington
Gray Television price target raised to $25 from $23 at Barrington
05/03/21 Barrington
Gray creates added scale with Meredith's broadcast assets, says Barrington
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/05/21 Loop Capital
Gray Television price target raised to $25 from $23 at Loop Capital
GTN Gray Television
$22.82 /

+0.08 (+0.35%)

GTN Gray Television
$22.82 /

+0.08 (+0.35%)

GTN Gray Television
$22.82 /

+0.08 (+0.35%)

Recommendations
Intuitive Surgical price target raised to $323 from $306 at Deutsche Bank » 06:50
10/20/21
10/20
06:50
10/20/21
06:50
ISRG

Intuitive Surgical

$336.63 /

+4.45 (+1.34%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

06:35 Today Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
04:59 Today Piper Sandler
Intuitive Surgical price target raised to $330 from $323 at Piper Sandler
10/01/21 Citi
Intuitive Surgical downgraded to Neutral from Buy at Citi
09/10/21 Stifel
Intuitive Surgical CFO commentary suggests negative revenue impact, says Stifel
ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

General news
European stock markets are narrowly mixed » 06:50
10/20/21
10/20
06:50
10/20/21
06:50
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Recommendations
Synchrony price target raised to $65 from $58 at Deutsche Bank » 06:49
10/20/21
10/20
06:49
10/20/21
06:49
SYF

Synchrony

$52.36 /

+1.33 (+2.61%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYF Synchrony
$52.36 /

+1.33 (+2.61%)

SYF Synchrony
$52.36 /

+1.33 (+2.61%)

06:23 Today Citi
Synchrony price target raised to $56 from $51 at Citi
04:47 Today JPMorgan
Synchrony downgraded to Neutral from Overweight at JPMorgan
09/10/21 Jefferies
Synchrony well positioned in evolving markets, says Jefferies
09/10/21 Credit Suisse
Synchrony price target raised to $63 from $59 at Credit Suisse
SYF Synchrony
$52.36 /

+1.33 (+2.61%)

SYF Synchrony
$52.36 /

+1.33 (+2.61%)

SYF Synchrony
$52.36 /

+1.33 (+2.61%)

SYF Synchrony
$52.36 /

+1.33 (+2.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.